The company I’m going to tell you about today brings a new twist to two frequent subjects for biotech investors: cancer and stem cells.
The post Why Stem Cells Can Be a Pernicious, Spreading Evil and the Biotech Set to Earn Billions Stopping Them appeared first on Agora Financial.